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The photoreceptor cell–specific ATP-binding cassette transporter gene (ABCA4; previously denoted “ABCR”) is
mutated in most patients with autosomal recessive (AR) Stargardt disease (STGD1) or fundus flavimaculatus (FFM).
In addition, a few cases with AR retinitis pigmentosa (RP) and AR cone-rod dystrophy (CRD) have been found
to have ABCA4 mutations. To evaluate the importance of the ABCA4 gene as a cause of AR CRD, we selected 5
patients with AR CRD and 15 patients with isolated CRD, all from Germany and The Netherlands . Single-strand
conformation–polymorphism analysis and sequencing revealed 19 ABCA4 mutations in 13 (65%) of 20 patients.
In six patients, mutations were identified in both ABCA4 alleles; in seven patients, mutations were detected in one
allele. One complex ABCA4 allele (L541P;A1038V) was found exclusively in German patients with CRD; one
patient carried this complex allele homozygously, and five others were compound heterozygous. These findings
suggest that mutations in the ABCA4 gene are the major cause of AR CRD. A primary role of the ABCA4 gene
in STGD1/FFM and AR CRD, together with the gene’s involvement in an as-yet-unknown proportion of cases
with AR RP, strengthens the idea that mutations in the ABCA4 gene could be the most frequent cause of inherited
retinal dystrophy in humans.
Inherited chorioretinal dystrophies show a high degree
of clinical and genetic heterogeneity (RetNet Web site).
Clinical classification is relatively straightforward for
those diseases that display typical fundoscopic and elec-
trophysiological abnormalities—for example, gyrate at-
rophy (MIM 258870), choroideremia (MIM 303100),
Stargardt disease (STGD1 [MIM 248200]), and Best vi-
telliform macular dystrophy (MIM 153700). Linkage
studies in each of these diseases have suggested the in-
volvement of a single locus, thereby facilitating the po-
sitional cloning of the underlying genes (Valle and Simell
1989; Cremers et al. 1990; Allikmets et al. 1997b; Pe-
trukhin et al. 1998). In other inherited chorioretinal dis-
eases, however, the clinical and genetic classification is
much more difficult, because the phenotypes are less dis-
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tinctive. Consequently, the identification of the genes in-
volved in this group of retinal disorders often relies on
a “brute force” approach, in which promising candidate
genes are screened for mutations in a large cohort of
patients with chorioretinal dystrophies (Dryja 1997 and
references therein). Traditionally, retinitis pigmentosa
(RP [MIM 268000]) is considered a rod-cone dystrophy,
with earlier and more serious involvement of the rod
photoreceptors as compared with cone photoreceptors.
Conversely, there is a group of patients in whom the
cone degeneration is more prominent than the degen-
eration of rods. In this cone-rod pattern of retinal dys-
trophy, or cone-rod dystrophy (CRD [MIM 120970,
MIM 601777, MIM 600624, MIM 603649, MIM
604116, MIM 600977]), the photopic cone b-wave am-
plitude is reduced more than the scotopic rod b-wave
amplitude in the electroretinogram (ERG) (Szlyk et al.
1993). At the end stages of both rod-cone and cone-rod
dystrophy, the ophthalmologic characteristics tend to co-
alesce, in part because the chorioretinal degenerations
follow a common apoptotic pathway (Chang et al.
1993).
Recent studies have suggested that the photoreceptor-
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Figure 1 Fundus appearance in four patients with CRD. a, Patient 11872, with perifoveal atrophy of the retinal pigment epithelium (RPE)
(bull’s eye) and atrophy of the RPE outside the macula. b, Patient 9633, with pericentral atrophy of the RPE. Arteries are slightly attenuated.
c, Patient 9378, with central hypo- and hyperpigmentation, patchy atrophy of the RPE temporal to the macula, normal vessels, and normal
optic disk. d, Patient 9369, with atrophy of the RPE around the optic disk, bone spicules along arteries and venules in the midperiphery, and
attenuated arterioles. The periphery of the retina is normal. Patients 9378 (c) and 9369 (d) were classified as atypical.
specific ATP-binding cassette transporter ABCR—re-
cently renamed “ABCA4” (MIM 601691)—works as an
N-retinylidene-phosphatidylethanolamine flippase on the
disk membrane of both cone and rod photoreceptor cells
(Sun et al. 1999; Weng et al. 1999; Molday et al. 2000).
We and others have shown the involvement of theABCA4
gene in STGD1/FFM and in a few families and patients
with autosomal recessive (AR) RP (RP19 [MIM601718])
and AR CRD (CORD3 [MIM 604116]) (Allikmets et al.
1997b; Cremers et al. 1998; Martinez-Mir et al. 1998;
Lewis et al. 1999; Maugeri et al. 1999; Papaioannou et
al. 2000). Moreover, heterozygous ABCA4 mutations
were found in 16% of patients with age-related macular
degeneration (AMD [MIM 153800]) (Allikmets et al.
1997a). Although the significance of this finding is under
debate (Stone et al. 1998), at least two ABCA4mutations
(G1961E and D2177N) have been shown, in a large mul-
ticenter study, to be statistically more frequent in patients
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Table 1
ABCA4 Mutations in Patients with CRD
PATIENT INHERITANCE
ABCA4 ALLELE 1 ABCA4 ALLELE 2
Nucleotide Changes Effects Nucleotide Changes Effects
9250a Isolated 1622TrC;3113CrT L541P;A1038Vb 194GrA G65Eb
9303 AR 1622TrC;3113CrT L541P;A1038Vb
9336 Isolated 6658CrT Q2220X
9369a AR 6601–6602delAG Frameshift
9370 Isolated 1622TrC;3113CrT L541P;A1038Vb
9371 Isolated 1622TrC;3113CrT L541P;A1038Vb 1622TrC;3113CrT L541P;A1038Vb
9378a Isolated 768GrT 5′ Splice mutationb
9553 AR 2588GrC DG863/G863Ab IVS35del-2r2del4 3′ Splice mutation
9633 Isolated 1622TrC;3113CrT L541P;A1038Vb 4469GrA C1490Yb
9650 Isolated 3364GrA E1122Kb
9887 Isolated 4793CrA A1598D 6329GrA W2110X
11872 Isolated 634CrT R212Cb
13163a AR 1622TrC;3113CrT L541P;A1038Vb IVS361GrA 5′ Splice mutationb
a Patient with atypical CRD.
b Previously described in patients with STGD1 (Rozet et al. 1998; Fishman et al. 1999; Lewis et al. 1999; Maugeri
et al. 1999).
with AMD compared with controls (Allikmets and The
International ABCR Screening Consortium 2000).
These studies suggest a model in which themost severe
retinal disorder associated with ABCA4 mutations, RP,
is caused by two ABCA4 null alleles, whereas CRD and
STGD1 are due to combinations of ABCA4 mutations
yielding residual ABCA4 function (Cremers et al. 1998;
Martinez-Mir et al. 1998; van Driel et al. 1998; Allik-
mets 1999; Lewis et al. 1999; Maugeri et al. 1999;
Shroyer et al. 1999; Lewis and Lupski 2000). On the
basis of this model and the grouping of ABCA4 muta-
tions in different classes of severity, we estimated that
ABCA4 mutations could be responsible for CRD in 1
in 50,000 individuals (Maugeri et al. 1999). Since AR
CRD represents a relatively rare disorder, we hypothe-
sized that ABCA4 could be an important cause of AR
CRD. In this study, we tested this hypothesis by eval-
uating the ABCA4 gene in patients with AR CRD.
The ABCA4 genotype-phenotype–correlation model
(Cremers et al. 1998; van Driel et al. 1998; Maugeri et
al. 1999) suggests that retinal dystrophies form a phe-
notypic continuum. In this study, we selected a group
of patients whose condition clearly is clinically distinct
from STGD1 and classic RP. Clinical investigations were
performed in two different centers: the Department of
Ophthalmology at University Medical Centre in Nij-
megen and the Augenklinik in Heidelberg. At the time
of diagnosis, the ophthalmologists were not aware of
the results of the mutation analysis.
Rod-cone and cone-rod patterns of retinal degenera-
tion were diagnosed predominantly on the basis of the
ERG patterns. Patients were diagnosed as having CRD
when the b-wave of the photopic ERG (cone response)
was more severely reduced than the b-wave of the sco-
topic ERG. In addition, these patients demonstrated the
following features: decreased visual acuity, impaired
color vision, central or paracentral scotomas, and fun-
doscopic evidence of maculopathy. Patients with either
STGD1 or fundus flavimaculatus were excluded from
this study. Yellow-white, irregularly shaped flecks in the
posterior pole and macular atrophy in the later stages
of the disease were considered characteristic features of
these types of inherited macular degeneration. Further-
more, these patients often demonstrate blocking of the
normal background fluorescence, on fluorescein angi-
ography, and normal or nearly normal full-field ERG
results. Patients with RP show scotopic rod amplitudes
more severely reduced than their photopic cone ampli-
tudes and typically develop night blindness and pro-
gressive impairment of the midperipheral visual field in
adolescence. Fundoscopic abnormalities include nar-
rowed retinal vessels, bone-spicule pigmentation, and
waxy pallor of the optic disk. Patients with these RP
characteristics were also excluded from this study.
Twenty unrelated patients were included in this study.
In five families, two or more siblings were affected, sug-
gesting AR inheritance. In each of the remaining 15 fam-
ilies, only one patient with CRD was identified. Thirteen
of these patients were considered typical CRD cases.
Representative fundus photographs are shown in figure
1a and b. In seven patients, either the ophthalmologic
examination was not complete, or some clinical findings
commonly not associated with CRD were observed, al-
though the ERG recordings showed a cone-rod type of
retinal degeneration. Three patients (9250, 9369, and
9661) demonstrated narrow retinal vessels and bone
spicules in the midperiphery in the later stages of their
disease (fig. 1d). One patient (9378) showed typical
patchy areas of chorioretinal atrophy in the midperi-
phery (fig. 1c). In another patient (8547), there was only
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Figure 2 DNA sequences in patients carrying the complex ABCA4 allele L541P;A1038V. a–b, Normal nucleotide sequences of exon 12
(a) and exon 21 (b) in a control individual. c–d, Heterozygous 1622TrC (c) and 3113CrT (d) nucleotide changes in patient 9370. e–f,
Homozygous 1622TrC (e) and 3113CrT (f) nucleotide changes in patient 9371.
minimal progression of the retinal dystrophy. Visual
fields were not available in patient 11630. His ERG
showed virtually extinguished cone responses in the
presence of slightly subnormal rod responses. Finally, in
patient 13163, the retinal dystrophy was in a final stage,
with nonrecordable ERG patterns. These seven patients
were therefore classified as having “atypical” CRD.
Using the single-strand conformation polymorphism
(SSCP) and direct-sequencing techniques (Allikmets et
al. 1997b; Gerber et al. 1998; Maugeri et al. 1999), we
searched for mutations in the 50 exons and flanking
intron sequences of the ABCA4 gene. Nineteen ABCA4
mutations were identified in 13 of 20 patients (table 1).
In six patients, mutations were found in both ABCA4
alleles; in seven patients, one ABCA4 mutation was
found. ABCA4 mutations were identified in 4 (80%) of
5 patients with AR CRD and in 9 (60%) of 15 patients
with isolated CRD. Thirteen mutantABCA4 alleleswere
found in 9 of 13 patients who showed the “classic”
symptoms of CRD. Six mutantABCA4 alleles were iden-
tified in four of seven patients classified as having atyp-
ical CRD.
Among 13 different mutations, 8 had been identified
previously in patients with STGD1 and, with the excep-
tion of the frequent 2588GrC founder mutation (Maug-
eri et al. 1999), were not present in100 healthy control
individuals (Fishman et al. 1999; Lewis et al. 1999;
Maugeri et al. 1999). Five mutations were novel. One
is a missense mutation (A1598D) that was not found in
100 control individuals. Four are thought to represent
null mutations, either because they introduce a stop
codon (W2110X and Q2220X), result in a frameshift
(6601–6602delAG), or disrupt a splice site (IVS35-
2r2del4). A complex L541P;A1038V allele was found
in 7 of 19 mutant alleles. Surprisingly, this complex
ABCA4 allele was exclusively found in 6 of 14 German
patients with CRD. One patient carried this complex
allele homozygously, three patients were compound het-
erozygotes, and two patients were heterozygous (table
1 and fig. 2).
In this study, we identified ABCA4 mutations in 65%
of the patients investigated, with no significant difference
between patients that we classified as having typical ver-
sus atypical CRD (69% vs. 57%). In total, ABCA4 mu-
tations have been identified in 80% of the patients with
AR CRD and in 60% of those with isolated CRD. As-
suming AR inheritance for all patients included in this
study, we identified ABCA4 mutations in 19 (47.5%) of
the 40 alleles. In patients with STGD1, a disease that is
thought to be genetically homogeneous, ABCA4 mu-
tation analysis revealed mutations in ∼60% of the alleles
(Lewis et al. 1999; Maugeri et al. 1999). Apparently, a
proportion (∼30%) of the ABCA4 mutations currently
are missed because of the limitations of the SSCP anal-
ysis technique and because many splice mutations could
be located in the noncoding sequence. Hence, it is pos-
sible that some of the seven CRD patients in whom we
did not find anABCA4mutation do in fact carryABCA4
mutations. Moreover, some of the six cases of isolated
CRD without ABCA4 mutations might be caused by
non–ABCA4-associated de novo autosomal dominant
gene defects. These data suggest that, in 170% of pa-
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Figure 3 Genotype-phenotype–correlationmodel and estimated incidence ofABCA4mutations in patientswith retinal dystrophies (adapted
from work by van Driel et al. [1998]). The model shows the inverse correlation between the ABCA4 residual activity and the severity of the
retinal dystrophy. The most severe phenotype, RP, is caused by two null/severe ABCA4 mutations. If the ABCA4 activity is partially retained,
patients will develop either CRD, as the result of a severe mutation inherited together with a moderate mutation, or STGD1, as the result of
a combination of a severe and a mild ABCA4 mutation.
tients with AR CRD, the disease is due to pathological
ABCA4 mutations. We conclude that mutations in the
ABCA4 gene are the major cause for AR CRD.
A prominent pathological role of ABCA4 in AR CRD
underscores the “ABCA4 genotype-phenotype model”
(fig. 3), in which we predicted AR CRD to occur when-
ever the ABCA4 activity is severely but not completely
compromised—for example, by a combination of “mod-
erate” and “severe” ABCA4 mutations (Cremers et al.
1998; van Driel et al. 1998; Maugeri et al. 1999). This
model was based in part on the observation that two
ABCA4 null mutations were invariably found in families
with atypical AR RP (Cremers et al. 1998; Martinez-
Mir et al. 1998) and in part on genotype-phenotype
comparison in a family with RP and CRD (Cremers et
al. 1998) and in patients with STDG1 (Allikmets et al.
1997b; Lewis et al. 1999; Maugeri et al. 1999). A fre-
quent mild ABCA4 founder mutation (2588GrC) was
found in 37% of European patients with STGD1 (Maug-
eri et al. 1999) and was never found homozygously in
this or other groups of patients (Allikmets et al. 1997b;
Lewis et al. 1999; Maugeri et al. 1999). In most of the
compound-heterozygous patients with STGD1, the
2588GrCmutation was accompanied by severeABCA4
mutations (Maugeri et al. 1999).
Although we consider the genotype-phenotype model
an oversimplification of the diverse functional effects
that mutations can have on the presumed N-reti-
nylidene-phosphatidylethanolamine flippase activity of
ABCA4 (Sun et al. 1999; Weng et al. 1999) and on
ABCA4-associated pathology, it allows us to evaluate
the severity of novel mutations and of combinations
thereof and to test the model’s validity in patients with
ABCA4-associated pathology other than STGD1. On
the basis of the model, patients with CRD should not
carry two null ABCA4 alleles. Although the number of
patients with CRD in which both ABCA4mutations are
found is still low and the consequences of individual
mutations have not been functionally tested, this indeed
seems to be the case.
According to the model (fig. 3), the mild 2588GrC
mutation, in combination with an ABCA4 mutation on
the other allele, should cause STGD1 and not CRD or
RP. Nevertheless, one patient with CRD (9553) was a
compound heterozygote for the 2588GrCmutation and
a severe splice-site mutation. As reported elsewhere in
patients with STGD1 (Lewis et al. 1999; Rozet et al.
1999; Shroyer et al. 2000), it is possible that patient
9553 carries an allele with the 2588GrC mutation and
another, as-yet-undetected mutation. Moreover, the pau-
city of the 2588GrC mutation in patients with CRD is
in contrast to its frequent occurrence in Western Euro-
pean patients with STGD1 (1/20 cases with CRD vs. 15/
40 cases with STGD1 [Maugeri et al. 1999]; ,P ! .01
one-sided Fisher’s exact test), strengthening our hypoth-
esis that it only contributes to STGD1 pathology. Seven
alleles in six German patients with CRD were found to
carry twomissense mutations (L541P;A1038V). The fre-
quency of this allele is surprisingly high in our group of
patients with CRD, comparable to the frequency of the
2588GrC ABCA4 founder mutation in European pa-
tients with STGD1 (7/40 alleles in patients with CRD
vs. 15/80 alleles in patients with STGD1) (Maugeri et
al. 1999). The ABCA4 allele carrying only the A1038V
mutation is one of the most frequent alleles in patients
with STGD1 in the United States (15/150) (Lewis et al.
1999). However, among a total of 357 non-German pa-
tients with STGD1, only 4 (1.1%) were shown to carry
the L541P;A1038V allele (Rozet et al. 1998; Fishman
et al. 1999; Lewis et al. 1999; Maugeri et al. 1999;
Papaioannou et al. 2000; Simonelli et al. 2000). In con-
trast, the complex allele was found in 22 (14.2%) of
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155 German patients with STGD1 (Maugeri et al. 1999;
B. H. Weber, personal communication), indicating that
this complex allele most likely is not specifically involved
in CRD.
In conclusion, we have found that, despite the high
clinical variability observed among patients with CRD,
mutations in the ABCA4 gene are responsible for the
majority of the cases. These findings confirm our pre-
vious hypothesis on the importance of ABCA4 involve-
ment in CRD (Maugeri et al. 1999), which is surprising,
in view of the high degree of genetic heterogeneity seen
in other retinal dystrophies.
Future studies will concentrate on theABCA4 analysis
of patients with AR RP, which, on the basis of our ge-
notype-phenotype model and previous estimates (Maug-
eri et al. 1999), should carry ABCA4 mutations in ∼8%
of the cases. Since other known AR RP genes are mu-
tated in 5% of the patients (Dryja et al. 1997, 1999;
Rivolta et al. 2000), mutations in ABCA4 may well be
the most frequent cause of nonsyndromic retinal dys-
trophy in humans.
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